✨
AI Summary
- Oncology biosimilars expand access and manage healthcare costs.
- Future opportunities require scientific innovation beyond patent monitoring.
- Experts discuss evolving standards and market dynamics for next-gen biosimilars.
Guests on This Episode
CF
Colin Farquharson
1 podcast appearance
ML
Martin Lachs
1 podcast appearance